INTRODUCTION
============

Acarbose(O-4,6-dideoxy-4-\[\[(1S,4R,5S,6S)-4,5,6-tri-hydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl\] amino\]-α-D-glucopyranosyl-(1-\>4)-O-α-D-glucopyranosyl-(1-\>4)-D-glucose) ([@R1]) is an oral alpha-glucosidase inhibitor, especially sucrase. It is given by mouth in the treatment of type 2 diabetes mellitus. It has also been studied for the treatment of reactive hypoglycemia, the dumping syndrome and certain types of hyperlipoproteinaemia ([@R2]). Miglitol (2R, 3R, 4R, -5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidine-triol) is a desoxynojirimycin derivative, also competitively inhibit glucoamylase and sucrase but has weak effects on pancreatic α-amylase ([@R3]).

Some analytical methods have been reported for the determination of the studied drugs. The reported methods for acarbose include Gas Chromatography-Mass spectrophotometry (GC-MS) ([@R4]), High Performance Liquid Chromatography (HPLC) ([@R5], [@R6]) and Capillary Electrophoresis (C.E.) ([@R6], [@R7]). As for miglitol, the reported methods were HPLC-MS ([@R8]) and C.E. ([@R9]).

To the best of our knowledge, no spectrophotometric methods have been reported for the analysis of acarbose and miglitol up till now. The results obtained were promising.

Several analytical techniques such as, spectrophotometry, chromatography, capillary electrophoresis, kinetic fluorimetry, flow injection analysis and chemiluminescence were utilized for selective oxidation and determination of many pharmaceutical compounds in formulations using potassium permanganate as reagent viz, benzenediols and 1,2,4 benzenetriol ([@R10]), perchloroethylene ([@R11]), arsenic (III) ([@R12]), methotrexate ([@R13]), propranolol ([@R14]), tetracyclines residues ([@R15]), psilocin and psilocybin ([@R16]), captopril ([@R17]), nickel ions ([@R18]), cefprozil ([@R19]), tramadol hydrochloride ([@R20]), ramipril ([@R21]), isoxsuprine ([@R22]), triprolidine ([@R23]), norfloxacin ([@R24]), fungicidal ethylenebisdithiocarbamate ([@R25]).

The aim of the present work was to study the reaction between the studied drugs with potassium permanganate in alkaline medium kinetically in an attempt to evaluate them in their dosage forms. The proposed method was simple and did not need sophisticated instruments or special skill, sensitive, rapid and readily adaptable to both the bulk drug and dosage forms.

EXPERIMENTAL
============

Reagents
--------

All chemicals used were of analytical reagent grade and the solvents were of spectroscopic grade. Potassium permanganate (Merck, Germany), 1 × 10^-2^ M and 7.6 × 10^-3^ M aqueous solutions.Sodium hydroxide (BDH, UK), 0.5 M aqueous solution.

Materials
---------

The different pharmaceutical preparations were purchased from the commercial source in the local market. they include: Acarbose was kindly offered from Alkan Pharma S.A.E., Egypt under licence of Bayer-Leverkusen, Germany.Miglitol was kindly offered from Sigma Pharmaceutical Industries, Egypt.Glucobay 50 tablets, labeled to contain 50 mg acarbose/tablet, Batch \# 080. The product of Alkan Pharma S.A.E., Egypt under licence of Bayer- Leverkusen, Germany.Glyset tablets, labeled to contain 50mg miglitol/ tablet, Batch \# 6191668. The product of Bayer Company, USA.

Stock solutions
---------------

Stock solutions of acarbose and miglitol were prepared by dissolving 100.0 mg of the studied drugs in 100 ml distilled water. Other concentrations were prepared by further dilution with distilled water. These solutions also were found stable for at least three days without alteration when kept in the refrigerator.

Apparatus
---------

UV-1601, Shimadzu recording spectrophotometer (P/N 206-67001) equipped with kinetic accessory provided with temperature controlled cell (TCC-240A) thermoelectric temperature. Recording range, 0-1; wavelength, 610 and 525 nm; factor 1; number of cell, 1; reaction time (min.) 15, 25 min.; cycle time, 0.1 min.

GENERAL PROCEDURES
==================

Construction of the kinetic calibration graphs
----------------------------------------------

Aliquot solutions containing 40-200 μg of standard acarbose and 10-100 μg of miglitol solutions were transferred into a series of 10-ml volumetric flasks. 1 ml of 0.5 M NaOH, followed by 1 or 2.5 ml of 1 × 10^-2^ M potassium permanaganate for acarbose and miglitol, respectively at 610 nm or 0.5 ml of 7.6 × 10^-3^ M for both drugs at 525 nm were added. The mixture was shaken well and completed to volume with distilled water. The increase at 610 nm or the decrease at 525 nm in the absorbance was scanned during 15 and 25 min. for acarbose and miglitol, respectively at ambient temperature (25°C) against an appropriate blank, prepared simultaneously. The reaction order was obtained by plotting log reaction rate (ΔA/Δt) over the specified time period *versus* log concentration of the drug. The calibration graphs and the regression equations were obtained by plotting the absorbance (A) or the difference in absorbance (ΔA) at the specified time *versus* concentration of the drug in μg/ml.

Procedure for the Determination of the Studied Compounds in Dosage Forms
------------------------------------------------------------------------

An accurately weighed quantity of the mixed contents of 10 powdered tablets equivalent to 100.0 mg of the drug was transferred into a 100 ml volumetric flask. The content of the flask was completed to 100 ml with distilled water then sonicated for 15 minutes and filtered. An aliquot of the cited solutions was taken and the above procedure was applied. The nominal content was calculated either from a previously plotted calibration graph or using the regression equation.

RESULTS AND DISCUSSION
======================

Oxidation of the studied drugs (Fig. [1](#F1){ref-type="fig"}) with KMnO~4~ was carried out in presence of NaOH. Trials were made to determine the drug through oxidation with KMnO~4~ in neutral and acidic media, but no apparent reaction products were observed. Potassium permanganate in alkaline medium oxidized the studied drugs and yielded the green color of manganate radical, which absorbs maximally at 610 nm (Fig. [2](#F2){ref-type="fig"}). The intensity of the color was increased with time, and so, a kinetic method was developed for the determination of these drugs at 610 nm. An alternative kinetic method for the determination of both drugs based upon measuring the decrease in the absorbance of KMnO~4~ at 525 nm was also developed.

![The structure formulae for the studied drugs.](IJBS-3-20_F1){#F1}

![Absorption spectra of the studied drugs after reaction with KMnO~4~/NaOH system. (a, b) The produced manganate ions after the reaction of KMnO~4~ with acarbose (20 μg/ml) or miglitol (10 μg/ml); (c, d) Oxidation products of acarbose and miglitol, respectively; (e) KMnO~4~ (1 × 10^-3^ M).](IJBS-3-20_F2){#F2}

Other oxidants were tested to determine the studied drugs, such as 10% H~2~O~2~, potassium persulphate in alkaline medium and potassium periodate in strong acid medium but all failed to give satisfactory results In case of H~2~O~2~ and persulphate, complete decomposition of the drug was observed, as revealed by the absence of any absorbing species. In case of periodate, oxidation of the drug resulted in hypsochromic shift and hypochromic effect, with maximum absorbance at 236 nm and this was in agreement with the reported results of oxidation of amino-alcohol compounds ([@R26]).

Study of Experimental Parameters
--------------------------------

The different experimental parameters affecting the formation of the oxidation product were studied. Variables were optimized by changing each in turn, while, keeping all others constant.

**Effect of KMnO~4~ concentration.** The influence of KMnO~4~ concentration on the absorbance of the reaction product was studied using different volumes (0.2-3.5 ml) of 1 × 10^-2^ M KMnO~4~. The reaction rate and hence maximum absorbance increased with increasing KMnO~4~ concentration at 610 nm. It was found that at least 1 or 2.5 ml of 1 × 10^-2^ M KMnO~4~ was adequate for the maximum absorbance of acarbose and miglitol, respectively as shown in Fig. [3](#F3){ref-type="fig"}, 0.5 ml of 7.6 × 10^-3^ M was sufficient for measuring the decrease in the absorbance at 525 nm for both drugs.

![Effect of KMnO~4~ on the absorbance intensity at 610 nm.](IJBS-3-20_F3){#F3}

**Effect of sodium hydroxide concentration.** The influence of the concentration of NaOH on the absorbance of the reaction product was studied using different volumes (0.2-1.4 ml) of 0.5 M NaOH. It was found that increasing the volume of 0.5 M NaOH would increase A or ΔA of the reaction up to 1 ml for both drugs at 610 nm or 525 nm after that NaOH has no effect on the absorbance as shown in Figures [4](#F4){ref-type="fig"} & [5](#F5){ref-type="fig"}.

![Effect of NaOH on the absorbance intensity at 610 nm.](IJBS-3-20_F4){#F4}

![Effect of NaOH on the absorbance intensity at 525 nm.](IJBS-3-20_F5){#F5}

**Effect of temperature.** The effect of temperature on the reaction rate was studied, it was found that, permanganate was reduced to manganate radical at room temperature (25°C) while at higher temperatures, manganese dioxide was produced. Therefore, room temperature was selected as the optimum temperature.

**Effect of time.** The effect of time on the reaction between KMnO~4~ and the studied drugs was studied. The absorbance of the reaction mixture was increased with time and never reach maximum in a reasonable time. Quantification was therefore made at fixed times of 15 min. for acarbose and 25 min. for miglitol (Figs.[6](#F6){ref-type="fig"}-[9](#F9){ref-type="fig"}).

![Absorption versus time graphs for the reaction between acarbose and KMnO~4~ at 610 nm. a) 4 μg/ml; b) 5 μg/ml; c) 10 μg/ml; d) 15 μg/ml; e) 20 μg/ml.](IJBS-3-20_F6){#F6}

![Absorption versus time graphs for the reaction between miglitol and KMnO~4~ at 610 nm. a) 1 μg/ml; b) 2 μg/ml; c) 4 μg/ml; d) 6 μg/ml; e) 8 μg/ml; f) 10 μg/ml.](IJBS-3-20_F7){#F7}

![Absorption versus time graphs for the reaction between acarbose and KMnO~4~ at 525 nm. a) Blank; b) 4 μg/ml; c) 5 μg/ml; d) 10 μg/ml; e) 15 μg/ml; f) 20 μg/ml.](IJBS-3-20_F8){#F8}

![Absorption versus time graphs for the reaction between miglitol and KMnO~4~ at 525 nm. a) Blank; b) 1 μg/ml; c) 2 μg/ml; d) 4 μg/ml; e) 6 μg/ml; f) 8 μg/ml; g) 10 μg/ml.](IJBS-3-20_F9){#F9}

Evaluation of the Kinetic Parameters
------------------------------------

As mentioned above, the reaction between KMnO~4~ and the studied drugs never reach completion and a decision was made to apply a kinetic method for their determination. Consequently, the order of the reaction and reaction rate constants were determined at 610 and 525 nm.

The rate of the reaction was found to be dependent on acarbose and miglitol concentrations. The rates were followed at room temperature with various concentrations in the range of 4-20 μg/ml for acarbose and 1-10 μg/ml for miglitol keeping KMnO~4~ and NaOH concentrations constant at the recommended levels mentioned above. The reaction rate obeys the following equation:
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The rate of the reaction may be estimated by the variable time method measurement ([@R27]), where A is the absorbance and t is the time in seconds. Taking logarithms of rates and drug concentrations (Table [1](#T1){ref-type="table"}), the previous equation is transformed into:
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###### 

Logarithm of the rate for different concentrations of the drugs at room temperature

  Compound    Log ΔA/At   Log \[drug\]   Regression equation              Correlation coefficient   Rate costant (S-1)   Order of reaction (n)
  ----------- ----------- -------------- -------------------------------- ------------------------- -------------------- -----------------------
                                                                                                                         
  At 610 nm                                                                                                              
   Acarbose   -4.138      -5.208         Log rate = 0.865 + 0.962 log C   0.9992                    7.328                0.962
              -4.069      -5.111                                                                                         
              -3.756      -4.810                                                                                         
              -3.586      -4.634                                                                                         
              -3.483      -4.509                                                                                         
   Miglitol                                                                                                              
              -4.309      -5.316         Log rate = 0.916 +0.982 log C    0.9999                    8.241                0.982
              -4.010      -5.015                                                                                         
              -3.714      -4.714                                                                                         
              -3.537      -4.538                                                                                         
              -3.420      -4.413                                                                                         
              -3.329      -4.316                                                                                         
  At 525 nm                                                                                                              
   Acarbose   -3.974      -5.208         Log rate = 1.243 +1.001 log C    0.9993                    17.49                1.001
              -3.872      -5.111                                                                                         
              -3.563      -4.810                                                                                         
              -3.380      -4.634                                                                                         
              -3.285      -4.509                                                                                         
   Miglitol   -4.359      -5.316         Log rate = 0.662 + 0.946 log C   0.9999                    4.591                0.946
              -4.090      -5.015                                                                                         
              -3.801      -4.714                                                                                         
              -3.630      -4.538                                                                                         
              -3.507      -4.413                                                                                         
              -3.420      -4.316                                                                                         

Plot of log reaction rate versus log drug concentration at 610 nm and 525 nm gave the regression equation, correlation coefficient, pseudo-order rate constant and order of the reaction which are indicated in Table [1](#T1){ref-type="table"}. These results indicate that the reaction is pseudo first order reaction in the drug concentration.

Selection of the best kinetic method
------------------------------------

Several kinetic techniques were adopted for the selection of the best method. Rate constant, fixed absorbance and fixed time methods ([@R28], [@R29]) were tried and the most suitable analytical method was selected taking into account the applicability, the sensitivity, i.e. the slope of the calibration graph and the correlation coefficient (r).

Rate constant method. Graphs of log absorbance versus time for acarbose and miglitol concentration in the range of 6.20 × 10^-6^ - 3.10 × 10^-5^ M and 4.83 × 10^-6^ - 4.83 × 10^-5^ M, respectively were plotted and all appeared to be rectilinear. Pseudo-first order rate constants (K\`) corresponding to different drug concentrations (C) were calculated from the slopes multiplied by --2.303 and are presented in Table [2](#T2){ref-type="table"}.

###### 

Application of the rate constant method in the quantification of the studied drugs with KMnO~4~

  Compound   \[drug\]         K\`/S^-1^         
  ---------- ---------------- ----------------- -----------------
                                                
  Acarbose   6.195 × 10^-6^                     -9.509 × 10^-4^
             7.744 × 10^-6^   -1.474 × 10^-3^   -9.230 × 10^-4^
             1.549 × 10^-5^   -1.350 × 10^-3^   -9.198 × 10^-4^
             2.323 × 10^-5^   -1.297 × 10^-3^   -8.338 × 10^-4^
             3.098 × 10^-5^   -1.188 × 10^-3^   -7.375 × 10^-4^
  Miglitol   4.826 × 10^-6^   -5.021 × 10^-4^   -1.005 × 10^-3^
             9.652 × 10^-6^   -4.982 × 10^-4^   
             1.931 × 10^-5^   -4.737 × 10^-4^   -9.557 × 10^-4^
             2.896 × 10^-5^   -4.506 × 10^-4^   -9.343 × 10^-4^
             3.861 × 10^-5^                     -9.112 × 10^-4^
             4.826 × 10^-5^   -4.291 × 10^-4^   -8.245 × 10^-4^

K\`, the pseudo first order rate constant.

Regression of (C) versus K\` gave equations: At 610 nmK\` = -1.56 × 10^-3^ + 11.76 C (r=0.9900) for acarboseK\` = -5.10 × 10^-4^ + 1.78 C (r=0.9850) for miglitolAt 525 nmK\`= -1.01 × 10^-3^ + 8.17C (r=0.9590) for acarboseK\`= -1.03 × 10^-3^ + 3.78 C (r=0.9570) for miglitol

where C is the molar concentration of the drugs.

Fixed absorbance method. Reaction times required to reach specific absorbance of redox reaction for different concentrations of acarbose and miglitol 1.55 × 10^-5^ -- 3.10 × 10^-5^ M and 1.93 × 10^-5^ -- 4.83 × 10^-5^ M, respectively were recorded. A preselected value of the absorbance (0.2) for acarbose and miglitol was fixed and the time was measured in seconds. The reciprocal of time (1/t) versus the initial concentration of drug was plotted. Table [3](#T3){ref-type="table"} and the following equations of the calibration graphs were obtained: At 610 nm1/t = -2.92 × 10^-2^ + 1847.57 C (r=0.9650) for acarbose1/t = -5.89 × 10^-3^ + 402.04 C (r=0.9960) for miglitolAt 525 nm1/t = -1.38 × 10^-2^ + 1010.16 C (r=0.9750) for acarbose1/t = -7.92 × 10^-4^ + 87.92 C (r=0.9960) for miglitol

where C is the molar concentration of the drugs.

###### 

Application of the fixed absorbance method in the quantification of the studied drugs with KMnO~4~

  Compound   \[drug\]         1/t (sec.^-1^)   
  ---------- ---------------- ---------------- ----------------
                                               
  Acarbose   1.549 × 10^-5^   1.684 × 10^-3^   2.874 × 10^-3^
             2.323 × 10^-5^   9.259 × 10^-3^   7.576 × 10^-3^
             3.098 × 10^-5^   3.030 × 10^-2^   1.852 × 10^-2^
  Miglitol   1.931 × 10^-5^   2.252 × 10^-3^   9.803 × 10^-4^
             2.896 × 10^-5^   5.376 × 10^-3^   1.701 × 10^-3^
             3.861 × 10^-5^   9.259 × 10^-3^   2.488 × 10^-3^
             4.826 × 10^-5^   1.389 × 10^-2^   3.546 × 10^-3^

Fixed time method. At a preselected fixed time, which was accurately determined, the absorbance was measured. Calibration graphs of the absorbance versus initial concentrations of acarbose and miglitol at fixed times of 15 and 25 min., respectively were established with the regression equations and correlation coefficients assembled in Table [4](#T4){ref-type="table"}.

###### 

Application of the fixed time method in the quantification of the studied drugs with KMnO~4~

  Compound     Time (min.)   Regression Equations    Correlation Coefficient
  ------------ ------------- ----------------------- -------------------------
                                                     
  At 610 nm                                          
    Acarbose   2.5           A= -0.0148 + 0 .0081C   r = 0.9980
               5             A= -0.0133 + 0.0180 C   r = 0.9997
               10            A= -0.0111 + 0.0207 C   r = 0.9998
               15            A= -0.0073 + 0.0224C    r = 0.9999
    Miglitol   5             A= -0.0105 + 0.0459 C   r = 0.9996
               10            A= -0.0094 + 0.0615C    r = 0.9997
               15            A= -0.0080 + 0.0694 C   r = 0.9998
               20            A= -0.0053 + 0.0741 C   r = 0.9998
               25            A= -0.0038 + 0.0780 C   r = 0.9999
  At 525 nm                                          
    Acarbose   2.5           A= -0.0170 + 0.0160 C   r = 0.9970
               5             A= -0.0173 + 0.0209 C   r = 0.9994
               10            A= -0.0094 + 0.0256 C   r = 0.9999
               15            A= -0.0043 + 0.0280 C   r = 0.9999
    Miglitol   5             A= -0.0067 + 0.0212 C   r = 0.9980
               10            A= -0.0095 + 0.0360 C   r = 0.9993
               15            A= 0.0002 + 0.0451 C    r = 0.9995
               20            A= 0.0045 + 0.0534 C    r = 0.9996
               25            A= 0.0098 + 0.0594C     r = 0.9998

It is clear that the slope increases with time and the most acceptable values of the correlation coefficient (r) was chosen as the most suitable time interval for the measurement.

As a conclusion, the fixed time method was chosen for quantification because it gave the best correlation coefficient in a reasonable time.

Quantification
--------------

After optimizing the reaction conditions, the fixed time method was applied to the kinetic determination of 4-20 μg/ml of acarbose and 1-10 μg/ml of miglitol in raw materials.

Analysis of the data gave the following regression equations:At 610 nmA= -7.332 × 10^-3^ + 2.243 × 10^-2^ C (r=0.9999) for acarboseA= -3.782 × 10^-3^ + 7.797 × 10^-2^ C (r=0.9999) for miglitolAt 525 nmA= -4.250 × 10^-3^ + 2.799 × 10^-2^ C (r=0.9999) for acarboseA= 9.787 × 10^-3^ + 5.939 × 10^-2^ C (r=0.9998) for miglitolwhere A is the absorbance and C is the concentration in μg/ml.

Statistical evaluation of the regression line gave the values of S~y/x~, S~a~, S~b~ which are indicated with the detection limits, quantification limits, % RSD and % Er. in Table [5](#T5){ref-type="table"}. These small values point out to the high precision of the proposed methods.

###### 

Collective parameters for the determination of the studied drugs by the proposed methods

  Compounds                      At 525 nm        At 610 nm                         
  ------------------------------ ---------------- ---------------- ---------------- ------------------
                                                                                    
  Concentration range (μg/ml)    1-10             4-20             1-10             4-20
  Detection limit (μg/ml)        0.179            0.081            0.089            0.189
  Quantification limit (μg/ml)   0.596            0.269            0.297            0.630
  S~y/x~                         4.220 × 10^-3^   1.210 × 10^-3^   2.762 × 10^-3^   2.269 × 10^-3^
  S~a~                           3.538 × 10^-3^   7.538 × 10^-4^   2.316 × 10^-3^   1\. 413 × 10^-3^
  S~b~                           5.411 × 10^-4^   8.950 × 10^-5^   3.541 × 10^-4^   1.678 × 10^-4^
  \% RSD                         1.269            0.719            1.186            1.095
  \% Er                          0.568            0.322            0.484            0.490

S~y/x~, Standard deviation of the residual; S~a~, Standard deviation of the intercept; S~b~, Standard deviation of the slope; % RSD, Relative standard deviation; % Er, Percentage error.

Statistical analysis of the results obtained by both the proposed and reference methods ([@R30], [@R31]) revealed no significant difference regarding the accuracy and precision as indicated by the Student t-test and F test ([@R32]), as shown in Table [6](#T6){ref-type="table"}. The reference method ([@R30]) for acarbose involved an optical rotation method given by Alkan Pharma S.A.E., Egypt under licence of Bayer- Leverkusen, Germany. While, the reference method ([@R31]) for miglitol was an HPLC method using acetonitrile and 25 mM sodium dibasic phosphate as mobile phase and detection at 205 nm. The data was provided by Sigma Pharmaceutical Industries, Egypt.

###### 

Application of the proposed methods for the determination of the studied drugs in their raw materials

  Compound    Proposed methods   Reference methods ([@R30], [@R31])                                                              
  ----------- ------------------ ------------------------------------ ---------------- ----------------------------------------- --------
                                                                                                                                 
  At 610 nm                                                                                                                      
  Acarbose    4.0                3.978                                99.45                                                      
              5.0                4.919                                98.38                                                      
              10.0               10.135                               101.35                                                     
              15.0               15.039                               100.26                                                     
              20.0               19.926                               99.63                                                      
  x ± S.D.                                                            99.81 ± 1.093    99.20 ± 0.400                             
  t                                                                   0.906            (2.447)[a](#T6FN2){ref-type="table-fn"}   
  F                                                                   7.47             (19.25)                                   
  Miglitol    1.0                1.021                                102.10                                                     
              2.0                2.015                                100.75           60.0                                      101.00
              4.0                3.937                                98.43            80.0                                      98.50
              6.0                6.019                                100.32           100.0                                     100.61
              8.0                8.000                                100.00                                                     
              10.0               10.009                               100.09                                                     
  x ± S.D.                                                            100.28 ± 1.189   100.04 ± 1.350                            
  t                                                                   0.274            (2.365)[a](#T6FN2){ref-type="table-fn"}   
  F                                                                   1.29             (19.30)                                   
  At 525 nm                                                                                                                      
  Acarbose    4.0                4.039                                100.98                                                     
              5.0                4.950                                99.00                                                      
              100                10.027                               100.27                                                     
              15.0               14.971                               99.81                                                      
              20.0               20.013                               100.06                                                     
  x ± S.D.                                                            100.02 ± 0.719   99.20 ± 0.400                             
  t                                                                   1.779            (2.447)[a](#T6FN2){ref-type="table-fn"}   
  F                                                                   3.23             (19.25)                                   
  Miglitol    2.0                1.967                                98.35                                                      
              4.0                4.045                                101.13           60.0                                      101.00
              6.0                6.067                                101.12           80.0                                      98.50
              8.0                8.052                                100.65           100.0                                     100.61
              10.0               9.911                                99.11                                                      
  x ± S.D.                                                            100.07 ± 1.270   100.04 ± 1.350                            
  t                                                                   0.032            (2.447)[a](#T6FN2){ref-type="table-fn"}   
  F                                                                   1.13             (19.25)                                   

Each result is the average of three separate determinations.

Figures in parentheses are the tabulated t and F values, respectively at *p*=0.05 ([@R32]).

The proposed methods were successfully applied for the determination of the studied drugs in their different dosage forms. The results obtained were in a good agreement with the reference methods ([@R30], [@R31]), as shown in Table [7](#T7){ref-type="table"}.

###### 

Application of the proposed methods for the determination of the studied drugs in pharmaceutical preparations

  Pharmaceutical preparations                              Proposed methods   Reference methods                                                              
  -------------------------------------------------------- ------------------ ------------------- ---------------- ----------------------------------------- -------
                                                                                                                                                             
  At 610 nm                                                                                                                                                  
    Glucobay 50 tablets[a](#T7FN2){ref-type="table-fn"}    5.0                5.008               100.16                                                     
    (Acarbose, 50 mg/tablet)                               10.0               10.091              100.91                                                     
                                                           15.0               15.218              101.45                                                     
  x ± S.D.                                                                                        100.84 ± 0.648   100.400 ± 0.400                           
  t                                                                                               1.002            (2.776)[c](#T7FN4){ref-type="table-fn"}   
  F                                                                                               2.62             (19.00)                                   
    Glyset 50 mg tablets[b](#T7FN3){ref-type="table-fn"}   2.0                1.978               98.90            60.0                                      97.26
    (Miglitol, 50 mg/tablet)                               4.0                4.025               100.63           80.0                                      98.71
                                                           8.0                8.099               101.24           100.0                                     99.66
  x ± S.D.                                                                                        100.26 ± 1.214   98.54 ± 1.208                             
  t                                                                                               1.740            (2.776)[c](#T7FN4){ref-type="table-fn"}   
  F                                                                                               1.01             (19.00)                                   
  At 525 nm                                                                                                                                                  
    Glucobay 50 tablets                                    4.0                4.044               101.10                                                     
    (Acarbose, 50 mg/tablet)                               10.0               10.062              100.62                                                     
                                                           20.0               20.220              101.10                                                     
  x ± S.D.                                                                                        100.94 ± 0.277   100.400 ± 0.400                           
  t                                                                                               1.923            (2.776)[c](#T7FN4){ref-type="table-fn"}   
  F                                                                                               2.086            (19.00)                                   
    Glyset 50 mg tablets                                   2.0                1.987               99.35            60.0                                      97.26
    (Miglitol, 50 mg/tablet)                               4.0                4.070               101.75           80.0                                      98.71
                                                           8.0                8.036               100.45           100.0                                     99.66
  x ± S.D.                                                                                        100.52 ± 1.201   98.54 ± 1.208                             
  t                                                                                               2.014            (2.776)[c](#T7FN4){ref-type="table-fn"}   
  F                                                                                               1.01             (19.00)                                   

Each result is the average of three separate determinations.

Product of Alkan Pharma S.A.E., Egypt under licence of Bayer-Leverkusen, Germany, Egypt;

Product of Sigma Pharma-ceutical industries, Egypt;

Figures in parentheses are the tabulated t and F values, respectively at *p*=0.05 ([@R32]).

Mechanism of the reaction
-------------------------

The data used in the optimization of KMnO~4~ concentration and the data of the calibration graphs were used to calculate the stoichiometry of the reaction adopting the limiting logarithmic method ([@R33]).

The ratio of the reaction between acarbose or miglitol and KMnO~4~ in alkaline medium was calculated by dividing the slope of KMnO~4~ curve over the slope of the drug curve (Figs. [10](#F10){ref-type="fig"} & [11](#F11){ref-type="fig"}). It was found that, the ratios were 1.012: 0.951 for acarbose and 0.943: 0.990 for miglitol pointing out to a ratio of 1:1 (KMnO~4~ to drug).

![Stoichiometry of the reaction between acarbose and KMnO~4~ adopting limiting logarithmic method ([@R33]). A) Variable concentrations of acarbose at constant KMnO~4~ concentration; B) Variable concentrations of KMnO~4~ at constant acarbose concentration.](IJBS-3-20_F10){#F10}

![Stoichiometry of the reaction between miglitol and KMnO~4~ adopting limiting logarithmic method ([@R33]). A) Variable concentrations of miglitol at constant KMnO~4~ concentration; B) Variable concentrations of KMnO~4~ at constant miglitol concentration.](IJBS-3-20_F11){#F11}

Based on the obtained molar reactivity, the reaction pathway is proposed to proceed as in Figure [12](#F12){ref-type="fig"}.

![The proposed pathway for the reaction between the studied drugs and potassium permanganate in alkaline medium.](IJBS-3-20_F12){#F12}

CONCLUSION
==========

The proposed methods are simple, accurate, precise, sensitive, rapid, low cost and selective compared to the reference methods ([@R30], [@R31]).

Furthermore, the proposed methods don't require elaboration of procedures, which are usually associated with chromatographic methods. The proposed methods were applied successfully for determination of the studied compounds in raw material as well as in different dosage forms. The only limitation for this method, if used in other pharmaceutical preparations containing antioxidant which will cause interference and this can be solved by using suitable solvent extraction.

From the above study some specific advantages in the application of kinetic methods can be expected ([@R35]): Selectivity due to the measurement of the evolution of the absorbance with the time of reaction instead of the measure of a concerete absorbance value.Possibility of no interference of other absorbent active compounds present in the commercial product, if they are exhibiting stability in the chemical reaction conditions established for the proposed kinetic method.Possibility of no interference of the colored and /or turbidity back ground of the sample.
